¼¼°èÀÇ ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·á ½ÃÀå
Autism Spectrum Disorder Treatment
»óǰÄÚµå : 1773981
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 383 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·á ¼¼°è ½ÃÀåÀº 2030³â±îÁö 29¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 22¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·á ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 4.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 29¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ °¢¼ºÁ¦´Â CAGR 5.6%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 14¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ç×Á¤½Åº´Á¦ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 100¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·á ½ÃÀåÀº 2024³â¿¡ 6¾ï 100¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024³âºÎÅÍ 2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 8.8%¸¦ ´õµë¾î, 2030³â±îÁö 6¾ï 1,450¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.9%¿Í 3.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·á ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·á ȯ°æÀº ¾î¶»°Ô º¯È­Çϰí Àִ°¡?

ÀÚÆó½ºÆåÆ®·³Àå¾Ö(ASD)ÀÇ Ä¡·á ȯ°æÀº Ä¡·áÀû °³ÀÔ°ú °³º°È­µÈ Ä¡·á Á¢±Ù¹ýÀÇ ¹ßÀü°ú ÇÔ²² ÁøÈ­Çϰí ÀÖÀ¸¸ç, ÇöÀç ASD Ä¡·á´Â Çൿġ·á, ¾à¸®ÇÐÀû ¿É¼Ç, ±×¸®°í °³ÀÎÀÇ °íÀ¯ÇÑ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇÑ Áö¿ø ±â¼úÀ» Æ÷°ýÇϰí ÀÖ½À´Ï´Ù. Á¶±â Áø´Ü ¹× ÁßÀç ÇÁ·Î±×·¥Àº ASD ¾Æµ¿ÀÇ ¹ß´Þ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Ä¡·áÁ¦¿Í AI ±â¹Ý µµ±¸¿Í °°Àº »õ·Î¿î Çõ½ÅÀº Ä¡·á È¿°ú¿Í Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í, ASD¸¦ °ü¸®ÇÏ´Â ¹æ½Ä¿¡ Å« º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.

ASD Ä¡·áÀÇ Çõ½ÅÀ» ÃËÁøÇÏ´Â Æ®·»µå´Â ¹«¾ùÀΰ¡?

ASDÀÇ À¯º´·ü Áõ°¡´Â »õ·Î¿î Ä¡·á¹ý ¹× Áø´Ü µµ±¸¿¡ ´ëÇÑ ¿¬±¸¸¦ ÃËÁøÇÏ´Â ¸î °¡Áö Æ®·»µå°¡ ASD Ä¡·áÀÇ Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â±â ¹× AI ±â¹Ý Áø´Ü Ç÷§Æû°ú °°Àº ±â¼ú ¹ßÀüÀ¸·Î ASD¸¦ Á¶±â¿¡ Á¤È®ÇÏ°Ô ¹ß°ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿ø°Ý Ä¡·á ¹× ¿ø°Ý ÁßÀç ÇÁ·Î±×·¥ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ƯÈ÷ Ä¡·á Á¢±Ù¼ºÀÌ ³·Àº Áö¿ª¿¡¼­ÀÇ Ä¡·á Á¢±Ù¼ºÀÌ °³¼±µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤¹ÐÀÇ·áÀÇ ¹ßÀüÀ¸·Î ASD ȯÀÚÀÇ ´Ù¾çÇÑ ¿ä±¸¿¡ ¸Â´Â ¸ÂÃãÇü ¾à¸®ÇÐÀû Ä¡·á¹ý °³¹ßÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

°¡Á·À̳ª °£º´ÀÎÀº Ä¡·á Á¢±Ù ¹æ½Ä¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´Â°¡?

°¡Á·°ú °£º´ÀÎÀº Æ÷°ýÀûÀ̰í ÀüÀÎÀûÀ̸ç Á¢±Ù °¡´ÉÇÑ Ä¡·á¸¦ ¿ËÈ£ÇÔÀ¸·Î½á ASD Ä¡·á Á¢±Ù¹ýÀ» Çü¼ºÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ºÎ¸ð¿Í °£º´ÀÎÀ» Ä¡·á ¼¼¼Ç¿¡ ÅëÇÕÇÏ´Â °¡Á· Á᫐ ÇÁ·Î±×·¥¿¡ ´ëÇÑ ¿ä±¸´Â °øµ¿ Ä¡·á ¸ðµ¨ÀÇ °³¹ß·Î À̾îÁ³½À´Ï´Ù. Áö¿ø ±×·ì°ú ±³À° ÀÚ¿øÀº °¡Á·¿¡°Ô ASD¸¦ ´õ Àß ÀÌÇØÇÏ°í °ü¸®ÇÒ ¼ö ÀÖ´Â ÈûÀ» ºÎ¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¿ª»çȸ ±â¹Ý Ä¡·á ¹× Á¶±â °³ÀÔ ÇÁ·Î±×·¥¿¡ ´ëÇÑ °­Á¶´Â È¿°úÀûÀ̰í Áö¼Ó°¡´ÉÇÑ Ä¡·á Àü·«À» ÃßÁøÇÏ´Â µ¥ ÀÖ¾î °£º´ÀÎÀÇ ¿µÇâ·ÂÀÌ Áõ°¡Çϰí ÀÖÀ½À» ¹Ý¿µÇÕ´Ï´Ù.

ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·á ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀº ASD À¯º´·üÀÇ Áõ°¡, Ä¡·á ±â¼úÀÇ ¹ßÀü, ¿¬±¸¿¡ ´ëÇÑ °ø°ø ¹× ¹Î°£ ÅõÀÚ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. Á¶±â Áø´Ü ¹× ÁßÀç ÇÁ·Î±×·¥À» Áö¿øÇÏ´Â Á¤ºÎÀÇ ³ë·ÂÀ¸·Î ASD Ä¡·á¸¦ À§ÇÑ ÅºÅºÇÑ ÀÎÇÁ¶ó°¡ ±¸ÃàµÇ°í ÀÖ½À´Ï´Ù. ¿ø°Ý Ä¡·á Ç÷§Æû°ú °°Àº µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ µµÀÔÀº ´Ù¾çÇÑ »ç¶÷µéÀÇ Ä¡·á Á¢±Ù¼ºÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±Ù°Å ±â¹Ý Ä¡·á¿Í ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ°í ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Ä¡·á À¯Çü(°¢¼ºÁ¦, Ç×Á¤½Åº´Á¦, ¼±ÅÃÀû ¼¼·ÎÅä´Ñ ÀçÈí¼ö ¾ïÁ¦Á¦, ¼ö¸éÁ¦, ±âŸ Ä¡·á À¯Çü), À¯Åë ä³Î(¼Ò¸Å ¾à±¹ À¯Åë ä³Î, º´¿ø ¾à±¹ À¯Åë ä³Î, ¿Â¶óÀÎ ¾à±¹ À¯Åë ä³Î), ¿ëµµ(ÀÚÆó¼º Àå¾Ö ¿ëµµ, ¾Æ½ºÆÛ°Å ÁõÈıº ¿ëµµ, ±¤¹ü¼º ¹ß´Þ Àå¾Ö ¿ëµµ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Autism Spectrum Disorder Treatment Market to Reach US$2.9 Billion by 2030

The global market for Autism Spectrum Disorder Treatment estimated at US$2.2 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Stimulants, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Antipsychotic Drugs segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$601.0 Million While China is Forecast to Grow at 8.8% CAGR

The Autism Spectrum Disorder Treatment market in the U.S. is estimated at US$601.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$614.5 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Autism Spectrum Disorder Treatment Market - Key Trends & Drivers Summarized

How Is the Landscape of Autism Spectrum Disorder Treatment Evolving?

The treatment landscape for Autism Spectrum Disorder (ASD) is evolving with advancements in therapeutic interventions and personalized care approaches. ASD treatments now encompass behavioral therapies, pharmacological options, and assistive technologies to address the unique needs of individuals. Early diagnosis and intervention programs are gaining momentum, improving developmental outcomes for children with ASD. Emerging innovations, such as digital therapeutics and AI-driven tools, are enhancing treatment effectiveness and accessibility, reflecting a significant shift in how ASD is managed globally.

What Trends Are Driving Innovation in ASD Treatment?

Several trends are driving innovation in ASD treatment. The increasing prevalence of ASD has spurred research into novel therapies and diagnostic tools. Technological advancements, such as wearable devices and AI-based diagnostic platforms, are enabling earlier and more accurate detection of ASD. The growing adoption of teletherapy and remote intervention programs is improving access to care, particularly in underserved areas. Additionally, the rise of precision medicine is fostering the development of tailored pharmacological treatments that address the diverse needs of individuals with ASD.

How Are Families and Caregivers Influencing Treatment Approaches?

Families and caregivers play a pivotal role in shaping ASD treatment approaches by advocating for inclusive, holistic, and accessible care. The demand for family-centric programs, which integrate parents and caregivers into therapy sessions, has led to the development of collaborative treatment models. Support groups and educational resources are empowering families to better understand and manage ASD. Furthermore, the emphasis on community-based care and early intervention programs reflects the growing influence of caregivers in driving effective and sustainable treatment strategies.

What Drives the Growth in the Autism Spectrum Disorder Treatment Market?

The growth in the autism spectrum disorder treatment market is driven by rising ASD prevalence, advancements in therapeutic technologies, and increased public and private investments in research. Government initiatives supporting early diagnosis and intervention programs are creating a robust infrastructure for ASD care. The adoption of digital health solutions, such as teletherapy platforms, is expanding access to treatment for diverse populations. Additionally, the growing emphasis on evidence-based therapies and personalized medicine is fostering innovation, ensuring sustained market growth.

SCOPE OF STUDY:

The report analyzes the Autism Spectrum Disorder Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Stimulants, Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Sleep Medications, Other Treatment Types); Distribution Channel (Retail Pharmacy Distribution Channel, Hospital Pharmacy Distribution Channel, Online Pharmacy Distribution Channel); Application (Autistic Disorder Application, Asperger Syndrome Application, Pervasive Developmental Disorder Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â